Peter J. Skrdla

1.3k total citations
66 papers, 1.0k citations indexed

About

Peter J. Skrdla is a scholar working on Materials Chemistry, Spectroscopy and Organic Chemistry. According to data from OpenAlex, Peter J. Skrdla has authored 66 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Materials Chemistry, 21 papers in Spectroscopy and 17 papers in Organic Chemistry. Recurrent topics in Peter J. Skrdla's work include Crystallization and Solubility Studies (25 papers), Thermal and Kinetic Analysis (19 papers) and Analytical Chemistry and Chromatography (19 papers). Peter J. Skrdla is often cited by papers focused on Crystallization and Solubility Studies (25 papers), Thermal and Kinetic Analysis (19 papers) and Analytical Chemistry and Chromatography (19 papers). Peter J. Skrdla collaborates with scholars based in United States, United Kingdom and Netherlands. Peter J. Skrdla's co-authors include Philip C. Dell’Orco, Philip D. Floyd, S. Scott Saavedra, Neal R. Armstrong, Y. Bereznitski, Vincent Antonucci, Dan Zhang, N. Wesley Norton, Joseph Cheriyan and Navin Goyal and has published in prestigious journals such as Blood, Chemistry of Materials and Analytical Chemistry.

In The Last Decade

Peter J. Skrdla

61 papers receiving 922 citations

Peers

Countries citing papers authored by Peter J. Skrdla

Since Specialization

Citations

This map shows the geographic impact of Peter J. Skrdla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Skrdla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Skrdla more than expected).

Fields of papers citing papers by Peter J. Skrdla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Skrdla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Skrdla. The network helps show where Peter J. Skrdla may publish in the future.

Co-authorship network of co-authors of Peter J. Skrdla

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Skrdla. A scholar is included among the top collaborators of Peter J. Skrdla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Skrdla. Peter J. Skrdla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Thermoanalytical and kinetic degrees of conversion in the application of general rate equation 2025 ·Thermochimica Acta ·Peter Šimon, Peter J. Skrdla, Tibor Dubaj, Zuzana Cibulková	4
2	Possible applications of the Polli dissolution mechanism: A case study using molecular dynamics simulation of Bupivacaine 2025 ·Journal of Pharmaceutical Sciences ·Peter J. Skrdla, Andrea Browning, (unknown), Jacob Gavartin	1
3	Estimating the maximal solubility advantage of drug salts 2021 ·International Journal of Pharmaceutics ·Peter J. Skrdla	7
4	Modelling sub-micron particle slip flow in liquid chromatography 2019 ·Talanta ·Peter J. Skrdla	1
5	On the Stability of Nano-formulations Prepared by Direct Synthesis: Simulated Ostwald Ripening of a Typical Nanocrystal Distribution Post-nucleation 2019 ·AAPS PharmSciTech ·Peter J. Skrdla, Husheng Yang	8
6	Predicting the solubility enhancement of amorphous drugs and related phenomena using basic thermodynamic principles and semi-empirical kinetic models 2019 ·International Journal of Pharmaceutics ·Peter J. Skrdla, Philip D. Floyd, Philip C. Dell’Orco	15
7	Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects 2019 ·American Journal of Cardiovascular Drugs ·Navin Goyal, Peter J. Skrdla, (unknown), (unknown), Disala Fernando, (unknown), N. Wesley Norton, Dennis L. Sprecher, Joseph Cheriyan	106
8	Predicted amorphous solubility and dissolution rate advantages following moisture sorption: Case studies of indomethacin and felodipine 2018 ·International Journal of Pharmaceutics ·Peter J. Skrdla, Philip D. Floyd, Philip C. Dell’Orco	11
9	Practical Estimation of Amorphous Solubility Enhancement Using Thermoanalytical Data: Determination of the Amorphous/Crystalline Solubility Ratio for Pure Indomethacin and Felodipine 2016 ·Journal of Pharmaceutical Sciences ·Peter J. Skrdla, Philip D. Floyd, Philip C. Dell’Orco	14
10	Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: Characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC 2013 ·Journal of Pharmaceutical and Biomedical Analysis ·Peter J. Skrdla, Dan Zhang	26
11	Separation of triphenyl atropisomers of a pharmaceutical compound on a novel mixed mode stationary phase: A case study involving dynamic chromatography, dynamic NMR and molecular modeling 2010 ·Journal of Chromatography A ·Xianyong Bu, Peter J. Skrdla, Peter G. Dormer, Y. Bereznitski	18
12	Practical comparison of 2.7μm fused-core silica particles and porous sub-2μm particles for fast separations in pharmaceutical process development 2009 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Mohammad H. Al‐Sayah, Peter J. Skrdla, Y. Bereznitski, (unknown), Naijun Wu	67
13	Use of a Quality-by-Design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols 2009 ·Journal of Pharmaceutical and Biomedical Analysis ·Peter J. Skrdla, Tao Wang, Vincent Antonucci, (unknown), Zhihong Ge, Dean Ellison, (unknown), (unknown), Jean Wyvratt	19
14	A high-temperature liquid chromatographic reactor approach for investigating the solvolytic stability of a pharmaceutical compound and an investigation of its retention behavior on a C18-modified zirconia stationary phase 2008 ·Journal of Pharmaceutical and Biomedical Analysis ·Peter J. Skrdla, (unknown), (unknown), Tao Wang	2
15	A simple model for complex dissolution kinetics: A case study of norfloxacin 2007 ·Journal of Pharmaceutical and Biomedical Analysis ·Peter J. Skrdla	29
16	Crystallization of Glycine During Freezing of a 40/60 w/w Sucrose/Glycine Excipient System: An Alternative to the Johnson–Mehl–Avrami (JMA) Equation for Modeling Dispersive Kinetics 2007 ·Journal of Pharmaceutical Sciences ·Peter J. Skrdla	8
17	An HPLC chromatographic reactor approach for investigating the hydrolytic stability of a pharmaceutical compound 2006 ·Journal of Pharmaceutical and Biomedical Analysis ·Peter J. Skrdla, (unknown), (unknown)	18
18	GC–MS Study of the formation of alkoxysilanes from a sol–gel precursor in a hydrophobic solution: A potential new route to hybrid molecular imprinted polymers 2006 ·Journal of Non-Crystalline Solids ·Peter J. Skrdla, (unknown), (unknown), Thomas P. O’Brien	15
19	Investigations into the chromatographic behavior of a doxorubicin–peptide conjugate 2002 ·Journal of Chromatography A ·Michael B. Hicks, Vincent Antonucci, Lance A. Riddle, (unknown), Peter J. Skrdla	4
20	A Simple Quantitative FT-IR Approach for the Study of a Polymorphic Transformation Under Crystallization Slurry Conditions 2001 ·Journal of Pharmaceutical and Biomedical Analysis ·Peter J. Skrdla, Vincent Antonucci, (unknown), Robert M. Wenslow, (unknown), George Zhou	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact